Tanger Factory Outlet Centers REIT Ord S (SKT)
$7.05 0.08 (1.12%)
19:51 EDT SKT Stock Quote Delayed 30 Minutes
Previous Close $7.05
Market Cap 665.40M
PE Ratio 9.79
Volume (Avg. Vol.) 2.15M
Day's Range 6.90 - 7.46
52-Week Range 4.05 - 17.94
Dividend & Yield 1.39 (19.76%)
SKT Stock Predictions, Articles, and Tanger Factory Outlet Centers REIT Ord S News
- From InvestorPlace
- From the Web
These stocks have yields over 6.5% that are well covered by earnings and low price-to-earnings ratios, making them clear buys for investors looking to cash in on dividends.
Talks about a coronavirus cure and Beyond Meat's expanding partnership were key talking points in the stock market today.
Short squeeze stocks can be highly profitable for adept traders. These three names could see rallies driven by short covering.
Walgreens, Uber, Tanger Outlets and Veeva were our top stock trades for Thursday. Let's look at the charts to see what's happening.
Amazon shares are breaking out and investors seem to hate REITs. Here's what happened in the stock market today.
Investors in their 40's should choose financially sound stocks to buy, especially in today's market where a downturn will likely happen.
The Trade Desk, Netflix, Alteryx, Twilio and Tanger were our top stock trades on Monday, after a brutal selloff in high-growth stocks.
Investors looking for retail stocks to buy should look no further than DG, SKT, KR, COST and BBY. All 5 look like solid prospects.
With the Fed cutting rates, the time to buy REITs is now. These 3 high-yielding REITS have a lot to gain after yesterday's rate cuts.
Investors who are feeling a little gutsy should consider these five stocks to buy to take advantage of the market's weariness right now.
Looking for great REITs? The letters to remember are FFO. Here are 5 that throw off plenty of cash and trade for dirt cheap.
Real estate stocks are a great way to gain consistent dividends and income increases. REITs work particularly well for long-term investors.
Picking stocks to buy on the dip is a lot easier in 2018 given the markets aren’t performing nearly as well as they did last year.
These 20 stocks are facing heavy pressure from short sellers - which could lead to epic gains if those traders are proven wrong.
Q2 earnings from Tanger will give ammunition to both SKT longs and shorts.
From Analyst Ratings
In a report released today, Jason McCarthy from Maxim Group initiated coverage with a Buy rating on Synthetic Biologics (SYN – Research Report) and a price target of $1.50. The company’s shares opened today at $0.51. According to TipRanks.com, McCarthy is a 5-star analyst with an average return of 16.6% and a 47.1% success rate.
From Simply Wall St
Anyone researching Synthetic Biologics, Inc. (NYSEMKT:SYN) might want to consider the historical volatility of the share price. Modern finance theory considers volatility to be a measure of risk, and there<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nysemkt-syn/synthetic-biologics/news/does-the-synthetic-biologics-inc-nysemktsyn-share-price-tend-to-follow-the-market-2/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader